GLP-1 Gummies and Pill Investigation
Marketed Like GLP-1. Not Delivered Like GLP-1.
Welcome. Thank you for your interest.
Lee Segui is investigating certain pills and gummies marketed as offering benefits similar to GLP-1 injectable medications.
What This Investigation Is About:
GLP-1 injectable medications are prescription drugs that have been studied for weight loss and metabolic effects. These medications are designed to enter the bloodstream in a specific way that allows them to work as intended. In contrast, some over-the-counter products—including pills and gummies—are being marketed as comparable alternatives, despite differences in how they are formulated, delivered, and absorbed by the body. Our investigation focuses on whether these products were marketed in a way that could lead consumers to expect results similar to prescription GLP-1 medications.
Why This Matters:
When products are marketed using comparisons to well-known medications, consumers may reasonably expect similar performance. If those expectations are not grounded in how the product actually works, that difference may be significant. We are evaluating whether certain marketing practices accurately reflected what consumers could expect from these products.
We are currently looking to speak with individuals who:
-Purchased a pill or gummy marketed as a GLP-1 product or as an alternative to GLP-1 injections.
-Saw or relied on marketing suggesting results similar to prescription GLP-1 medications.
-Purchased the product within the past 12 months.
-Did not experience the results they were led to expect
You do not need to have medical documentation to complete this form.
What to Expect:
This form helps us understand your experience and determine whether your situation aligns with our investigation. Submitting this form does not create an attorney-client relationship, and it does not obligate you to take any action. If your responses indicate a potential match, a member of our team may follow up with you.
If you believe a GLP-1 pill or gummy was marketed to you in a way that did not match your experience, we invite you to share more information.
Disclaimer: This form may be considered attorney advertising. The information provided is for general informational purposes only and is not intended as legal advice. Past results do not guarantee a similar outcome. The choice of a lawyer is an important decision and should not be based solely upon advertisements. Submitting your information does not create an attorney–client relationship. An attorney–client relationship will only be formed if and when a written representation agreement is signed. By providing your contact information, you consent to being contacted by our law firm (or its partners) about your potential claim. You are under no obligation to participate, and you may choose not to proceed after receiving more information. This matter will be handled on a contingency fee basis, meaning you will not owe attorneys’ fees unless there is a recovery. In some jurisdictions, you may still be responsible for costs and expenses, which will be explained before you decide whether to proceed. Attorney responsible for this content: Harper Segui Office address: 900 W. Morgan Street, Raleigh, NC, 27603 Privacy Notice: We respect your privacy. Your information will be kept strictly confidential and used only to evaluate your eligibility and contact you about this case. We will never sell or rent your data. Your details will only be shared with attorneys and staff working on this matter.
GLP-1 Gummies and Pill Investigation
Some medications are marketed as working like GLP-1 injections—but do not deliver the same results. We’re investigating whether consumers were misled into purchasing pills or gummies marketed as comparable alternatives to prescription GLP-1 drugs. Our focus is on products purchased within the last year that were advertised as offering similar weight loss or metabolic effects as injectable GLP-1 medications.